|
|
||||||||
The Annals of Thoracic Surgery, Vol 46, 309-316, Copyright © 1988 by The Society of Thoracic Surgeons
CL Webb, JJ Benedict, FJ Schoen, JA Linden and RJ Levy
Calcification is the principal mode of failure of bioprosthetic heart
valves (BPHV) fabricated from glutaraldehyde-pretreated porcine aortic
valves or bovine pericardium. Covalent binding of aminopropanehydroxy-
diphosphonate (APDP) to residual glutaraldehyde in pericardial BPHV tissue
was studied as an approach for the inhibition of calcification. BPHV tissue
was preincubated in 0.14 M APDP at pH 7.4, 9.0, and 11.0 for various
durations (1 hour to 8 days). The need for NaBH4 stabilization of the
tissue-bound APDP was also examined in vitro. The bound APDP was determined
using 14C-labeled APDP. APDP uptake was dependent on incubation duration
and pH. Calcification of APDP- pretreated BPHV was studied using 21-day rat
subdermal implants. Calcification inhibition was directly related to the
amount of tissue APDP incorporation. Inhibition of calcification to less
than 15% of control was achieved with a concentration of bound APDP of
greater than or equal to 30 nM/mg dry tissue with more than 1 hour of
incubation at pH 11.0 (bound APDP, 33.55 nM/mg; BPHV calcium content = 3.1
+/- 0.9 micrograms/mg). No adverse effects such as rat growth inhibition or
disruption of bone architecture were observed after any treatment.
Additionally, in vitro, NaBH4 stabilized tissue-bound APDP. In conclusion,
APDP covalently bound to residual aldehyde functions markedly inhibited
calcification of BPHV tissue. This inhibition was dependent on the amount
of APDP incorporated. NaBH4 stabilized APDP- glutaraldehyde covalent bonds.
ARTICLES
Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups
Division of Pediatric Cardiology, C.S. Mott Children's Hospital, University of Michigan Medical Center, Ann Arbor 48109-0576.
This article has been cited by other articles:
![]() |
F. J. Schoen and R. J. Levy Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and Prevention Ann. Thorac. Surg., March 1, 2005; 79(3): 1072 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gross Calcification of bioprosthetic heart valves and its assessment J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S6 - 8. [Full Text] [PDF] |
||||
![]() |
J. M. Gross Calcification of bioprosthetic heart valves and its assessment J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 428 - 430. [Full Text] [PDF] |
||||
![]() |
C. Shanthi and K. P. Rao Regulation of Biocalcification of Bovine Pericardial Tissue b Grafting Poly(Glycidyl Methacrylate-Butylacrylate) Copolymers Journal of Bioactive and Compatible Polymers, October 1, 1997; 12(4): 308 - 320. [Abstract] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |